|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-5-14
|
|
pubmed:abstractText |
The prognosis of patients with severe non-ischaemic dilated cardiomyopathy is variable. The predictive value of currently utilized tests is suboptimal. The purpose of this study was to determine the prognostic value of dobutamine-induced augmentation of left ventricular ejection fraction in patients with non-ischaemic dilated cardiomyopathy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 The European Society of Cardiology.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
849-56
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11350094-Adult,
pubmed-meshheading:11350094-Cardiomyopathy, Dilated,
pubmed-meshheading:11350094-Dobutamine,
pubmed-meshheading:11350094-Female,
pubmed-meshheading:11350094-Heart Failure,
pubmed-meshheading:11350094-Humans,
pubmed-meshheading:11350094-Male,
pubmed-meshheading:11350094-Middle Aged,
pubmed-meshheading:11350094-Predictive Value of Tests,
pubmed-meshheading:11350094-Prognosis,
pubmed-meshheading:11350094-Radionuclide Ventriculography,
pubmed-meshheading:11350094-Stroke Volume,
pubmed-meshheading:11350094-Survival Rate,
pubmed-meshheading:11350094-Ventricular Dysfunction, Left,
pubmed-meshheading:11350094-Ventricular Function, Left
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
|
|
pubmed:affiliation |
Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA.
|
|
pubmed:publicationType |
Journal Article
|
